Neocuspidization versus bioprosthesis in surgical replacement of the aortic valve: a propensity-matched comparative analysis of immediate and mid-term outcomes
Authors:
- 13 January 2026
- journal article
- research article
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 74 (7) , 635-647
Abstract
Objectives This study aims to compare the immediate and mid-term outcomes of Aortic Valve Neocuspidization (AVNeo) with surgical aortic valve replacement using a bioprosthesis (BioSAVR) to determine if neocuspidization can overcome limitations of current techniques. Methods From December 2016 to December 2023, 155 patients received AVNeo at the Heart Institute, while 301 underwent BioSAVR. Baseline characteristics were balanced using 1:1 propensity matching. Results 132 identical patient pairs were included in the analysis. Neocuspidization had longer ischemic times (98.67 ± 28.47 min vs. 66.76 ± 25.04 min, ρ < 0.001). Permanent pacemaker implantation (ρ = 0.072) and paravalvular leaks (ρ = 0.041) were more common in the BioSAVR group. Follow-up averaged 43.8 ± 27.30 months. Severe post-procedural aortic stenosis (PPAS) was more frequent after BioSAVR (3 (2.8%) vs. 1 (0.9%), ρ = 0.006), but AVNeo experienced more recurrent severe aortic regurgitation (AR) (3 (2.8%) vs. 0, ρ = 0.035). Reoperation rates were similar (AVNeo 3.1%, BioSAVR 1.5%, ρ = 0.680). Prosthetic valve endocarditis (PVE) was responsible for half (2 cases) of the AVNeo reoperations. Survival rate during follow-up was comparable: 92.8% (AVNeo) and 94.4% (BioSAVR), ρ = 0.672. Conclusions Immediate and mid-term AVNeo quality outcomes were comparable to those of BioSAVR. Transvalvular hemodynamics were better, and the incidence of PPAS was lower after AVNeo, supporting the recommendation of this procedure for patients at high risk of patient-prosthesis mismatch. During follow-up, AVNeo patients require close monitoring for recurrent AR and aggressive PVE prophylaxis. A multicenter long-term study is needed to confirm the stability of hemodynamic performance, the rate of Structural Valve Deterioration, and the incidence of PVE in AVNeo patients over the long term.Keywords
This publication has 23 references indexed in Scilit:
- Need for Permanent Pacemaker After Surgical Aortic Valve Replacement Reduces Long-Term SurvivalThe Annals of Thoracic Surgery, 2018
- Early and mid-term results of isolated aortic valve neocuspidization in patients with aortic stenosisGeneral Thoracic and Cardiovascular Surgery, 2018
- The Incidence and Consequence of Prosthesis-Patient Mismatch After Surgical Aortic Valve ReplacementThe Annals of Thoracic Surgery, 2018
- Aortic Valve Reconstruction with Use of Pericardial Leaflets in Adults with Bicuspid Aortic Valve Disease: Early and Midterm OutcomesTexas Heart Institute Journal, 2014
- Impact of residual regurgitation after aortic valve replacementEuropean Journal of Cardio-Thoracic Surgery, 2012
- Tensile Strength of Human Pericardium Treated with GlutaraldehydeAnnals of Thoracic and Cardiovascular Surgery, 2012
- Long-Term Results of the Leaflet Extension Technique in Aortic Regurgitation: Thirteen Years of Experience in a Single CenterThe Annals of Thoracic Surgery, 2009
- Up to 16 years follow-up of aortic valve reconstruction with pericardium: a stentless readily available cheap valve?☆European Journal of Cardio-Thoracic Surgery, 2005
- Dynamic analysis of the aortic valve using a finite element modelThe Annals of Thoracic Surgery, 2002
- Characterization of the immune response to valve bioprostheses and its role in primary tissue failureThe Annals of Thoracic Surgery, 2001